According to the results of GSEA in the T2DM group, ARHGEF9 was significantly downregulated in pathways related to amino acid metabolism and regulation (Figures 9A, B), whereas SLPI was significantly upregulated in pathways related to hormone regulation and cell interactions (Figures 9C, D). Here, ARHGEF9 is linked to type 2 diabetes mellitus.